Verastem, Inc. (2VSA.F)

EUR 4.28

(-35.15%)

Inventory Summary of Verastem, Inc.

  • Verastem, Inc.'s latest annual inventory in 2023 was - USD , down 0.0% from previous year.
  • Verastem, Inc.'s latest quarterly inventory in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Verastem, Inc. reported annual inventory of - USD in 2022, up 100.0% from previous year.
  • Verastem, Inc. reported annual inventory of -100.77 Million USD in 2021, down 0.0% from previous year.
  • Verastem, Inc. reported quarterly inventory of - USD for 2024 Q2, down 0.0% from previous quarter.
  • Verastem, Inc. reported quarterly inventory of - USD for 2023 Q1, down 0.0% from previous quarter.

Annual Inventory Chart of Verastem, Inc. (2023 - 2011)

Historical Annual Inventory of Verastem, Inc. (2023 - 2011)

Year Inventory Inventory Growth
2023 - USD 0.0%
2022 - USD 100.0%
2021 -100.77 Million USD 0.0%
2020 - USD -100.0%
2019 3.09 Million USD 846.79%
2018 327 Thousand USD 0.0%
2017 - USD 0.0%
2016 - USD 100.0%
2015 -154 Thousand USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%

Peer Inventory Comparison of Verastem, Inc.

Name Inventory Inventory Difference
BioNTech SE 357.7 Million EUR 100.0%
CureVac N.V. 24.82 Million EUR 100.0%
Biotest Aktiengesellschaft 419.1 Million EUR 100.0%
Biotest Aktiengesellschaft 419.1 Million EUR 100.0%
BRAIN Biotech AG 9.72 Million EUR 100.0%
Formycon AG 467 Thousand EUR 100.0%
Heidelberg Pharma AG 10.48 Million EUR 100.0%
Medigene AG 1.00 EUR 100.0%